Compare PHI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHI | GRFS |
|---|---|---|
| Founded | 1928 | 1940 |
| Country | Philippines | Spain |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.2B |
| IPO Year | 1995 | 2008 |
| Metric | PHI | GRFS |
|---|---|---|
| Price | $17.73 | $8.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.37 |
| AVG Volume (30 Days) | 161.2K | ★ 735.9K |
| Earning Date | 11-12-2026 | 07-28-2022 |
| Dividend Yield | ★ 6.11% | 3.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.83 | $1.89 |
| Revenue Next Year | $2.50 | $6.20 |
| P/E Ratio | ★ $10.44 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.71 | $6.96 |
| 52 Week High | $24.51 | $9.77 |
| Indicator | PHI | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 75.79 |
| Support Level | $17.12 | $7.18 |
| Resistance Level | $20.06 | $9.77 |
| Average True Range (ATR) | 0.40 | 0.27 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 24.58 | 99.63 |
PLDT Inc is a telecommunications and digital services provider. The group has three reportable operating segments: Wireless, Fixed Line, and Others. Maximum revenue is generated from its Fixed Line segment, which offers fixed line telecommunications services, servicing retail, corporate, and small and medium-sized enterprises clients. The Fixed Line business segment offers data, voice, and miscellaneous services. It also offers secure data centers, multi-cloud, cybersecurity, data, and artificial intelligence (AI) solutions through different subsidiaries. The Wireless segment generates revenue by offering access to mobile internet via smartphones, mobile broadband using pocket WiFi, or home WiFi using fixed wireless broadband devices. Geographically, the group operates in the Philippines.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.